Jason Douglas Wilson, Executive VP of Operations at REATA PHARMACEUTICALS INC (RETA), sold 42,100 shares at $100.00 ($5.5M) on 2019-10-14, disclosed to the SEC on 2019-10-15.
Open-market sale of $5.5M RETA by Executive VP of Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.00 | 15,000 | $1.5M | 27.5% |
| 2 | $145.55 | 11,800 | $1.7M | 31.5% |
| 3 | $145.55 | 11,800 | $1.7M | 31.5% |
| 4 | $146.61 | 300 | $44K | 0.8% |
| 5 | $146.61 | 300 | $44K | 0.8% |
| 6 | $148.46 | 2,900 |
| $431K |
| 7.9% |
| Total | $129.54 avg | 42,100 | $5.5M | 100% |
| Filing → |
| RETA | SELL | 2019-08-16 | $420K | — | Filing → |
| RETA | SELL | 2019-07-17 | $574K | — | Filing → |
| RETA | SELL | 2019-06-19 | $668K | — | Filing → |